Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus plus cyclophosphamide in metastatic or unresectable myxoid liposarcoma and conventional chondrosarcoma
2013-005155-32Phase 2Active
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sirolimus and cyclophosphamide in Myxoid/round cell liposarcoma (MRCLS) and chondrosarcoma, sponsored by Leiden University Medical Center. Primary endpoint: Time to progression. Started Dec 2014; status: active.
02
Drugs
sirolimuscyclophosphamide
03
Conditions
Myxoid/round cell liposarcoma (MRCLS)chondrosarcoma
Beyond the preview
Go deeper on 2013-005155-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005155-32.